The Cell biological changes during the development of sclerotic lesions are characterized by an increased deposition of extracellular matrix (ECM) proteins such as laminin, fibronectin, and collagens (1-3). The latter represent a family of proteins with at least 14 different members, which form the major structural part of the ECM (4). The ECM has been previously considered to be a relatively inert mass of proteins. However, recent reports have shown that it is subjected to a continuous turnover that accounts for a remodeling of -5-15% of total ECM per day (5). The ECM influences cell functions and is essentially involved in tissue-typespecific gene expression and proliferation (6-8). It is able to affect the differentiation state of a cell, and, consequently, alterations of the composition of the ECM modulate the responsiveness of cells to physiological stimuli such as growth factors, hormones, and cytokines (7). In addition, changes in the relative proportions of components of the ECM are apparently of crucial relevance for the pathogenesis of various diseases such as atherosclerosis (6, 9, 10). Here, the prominence of collagen as a major element of atherosclerotic plaques is well established, taking into account that 90% of the total collagen found in these lesions is formed by collagens type I and III (1). Furthermore, an increased expression of collagens IV, V, and VI was reported in human atherosclerotic plaques (1, 2).ECM metabolism is tightly regulated by a complex network of interactions, including (i) the de novo synthesis of compounds by interstitial cells; (ii) the degradation of existing ECM molecules by the action of various proteases, including members of the matrix metalloprotease (MMP) family; and (iii) the inhibition of protease activities by specific endogenous antagonists such as the tissue inhibitors of metalloproteinases (TIMPs) (11)(12)(13) (17,18). Fibroblasts were cultivated in RPMI 1640 medium supplemented with 10% fetal calf serum and 8 mM stabilized L-glutamine; VSMCs were cultivated in DMEM supplemented with 5% colostrum, 20 mM Hepes, and 8 mM L-glutamine. Subconfluent cultures (80% confluence) were used between passages two and six. Cells were synchronized by starvation for 48 hr in low-serum medium (0.1% fetal calf serum), replacing the medium every 24 hr. Quiescent cells were challenged with human recombinant PDGF BB (10 ng/ml; GIBCO/BRL) in the presence or absence of the drugs.